登入選單

返回Google圖書搜尋

Dupilumab Provides Acceptable Safety and Sustained Efficacy for Up to 4 Years in a Open-label Study of Adults with Moderate-to-severe Atopic Dermatitis

Lisa Beck (médico)

出版	Springer Healthcare Ibérica S.L., 2022
URL	http://books.google.com.hk/books?id=aTVb0AEACAAJ&hl=&source=gbs_api